Loading clinical trials...
Loading clinical trials...
Resection of the Primary Pancreatic Tumour and Thermal Hepatic Ablation Combined With Chemotherapy vs. Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer: A Randomized Controlled Trial
Conditions
Interventions
Thermal Ablation
Chemotherapy
Start Date
January 1, 2023
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
November 10, 2022
NCT04657068
NCT06445062
NCT04900818
NCT07432633
NCT04851119
NCT06005493
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions